NPS Pharmaceuticals (NPSP +1.8%) trades higher after the FDA accepts its Gattex drug application for review. Slicing through the firm's statement a bit - it appears that it didn't land a coveted "priority" review from the FDA.
Sent to 3,304 people who get email alerts on NPSP.
Get email alerts on NPSP »
Want to be faster and smarter on all your stocks?
Upgrade all your basic real-time alerts to PRO Alerts, for $20.